insights_auto
Bakit tumaas ang 4519 3.76%?
Tingnan ang Higit pang Detalyechevron_right
4519:TYO
Chugai Pharmaceutical Co Ltd
Â¥6,267.00
arrow_upward
+3.76%(+227.00) 1D
Okt 15, 3:30:00 PM GMT+9 · JPY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 4519...
Buksan
Â¥6,140
Mataas
Â¥6,285
Mababa
Â¥6,099
Mkt. cap
10.52T
Avg. na dami
2.96M
Dami
5.20M
Dividend
2.20%
Bawat tatlong buwang dividend
Â¥35
Petsa ng ex-dividend
Hun 29, 2026
P/E ratio
21.88
Mataas nang 52-wk
Â¥10,700
Mababa nang 52-wk
Â¥5,974
EPS
Â¥286
Mga natitirang share
547.19M
Bilang ng mga empleyado
5K
Buksan
Â¥6,140
Mataas
Â¥6,285
Mababa
Â¥6,099
Mkt. cap
10.52T
Avg. na dami
2.96M
Dami
5.20M
Dividend
2.20%
Bawat tatlong buwang dividend
Â¥35
Petsa ng ex-dividend
Hun 29, 2026
P/E ratio
21.88
Mataas nang 52-wk
Â¥10,700
Mababa nang 52-wk
Â¥5,974
EPS
Â¥286
Mga natitirang share
547.19M
Bilang ng mga empleyado
5K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
11 oras ang nakalipas
Chugai reports vamikibart data. Chugai Pharmaceutical stock costs EUR 35.28
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Tungkol sa Chugai Pharmaceutical Co Ltd